|Articles|March 1, 2001

CME: Preventing group B streptococcal infections with targeted therapy

Since the CDC recommendations have been put into practice, we've seen a dramatic decline in early-onset neonatal GBS infections. But an expert in the field discusses several unresolved issues and emphasizes the need for continued vigilance to keep the disease under control.


Related to this article